Distant recurrences in triple negative breast cancer (TNBC) according to androgen receptor (AR) status.

被引：0
|
作者：
Tung, Nadine M.
Garber, Judy Ellen
Hacker, Michele R.
Torous, Vanda
Nalven, Tessa
Alexander, Brian Michael
Lee, Larissa Janeen
Collins, Laura C.
Schnitt, Stuart J.
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Sch Publ Hlth, Boston, MA USA
[4] Brigham & Womens Canc Ctr, Dana Farber Canc Inst, Boston, MA USA
[5] Harvard Rad Onc Prog, Boston, MA USA
[6] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.1085
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1085
引用
收藏
页数：2
相关论文
共 50 条
  • [31] P16 Expression is correlated with Androgen Receptor (AR) expression in Triple-Negative Breast Cancers (TNBC)
    Yoon, Esther
    Wilson, Parker
    Irshaid, Lina
    Zuo, Tao
    Pinto, Marguerite
    Cole, Kimberly
    Harigopal, Malini
    LABORATORY INVESTIGATION, 2019, 99
  • [32] A phase 2 study evaluating orteronel, an inhibitor of androgen biosynthesis, in patients with androgen receptor (AR)-expressing metastatic triple-negative breast cancer (TNBC)
    Yardley, Denise A.
    Young, Robyn R.
    Adelson, Kerin B.
    Silber, Andrea L.
    Kommor, Michael D.
    Najera, Jose E.
    Daniel, Davey B.
    Peacock, Nancy W.
    Shastry, Mythili
    Hainsworth, John D.
    Burris, Howard A., III
    CANCER RESEARCH, 2021, 81 (04)
  • [33] CK14, FOXA1, and androgen receptor (AR) expression in patients (pts) with triple-negative breast cancer (TNBC)
    Gucalp, Ayca
    Krasne, Margaret D.
    Jakate, Kiran A.
    Drill, Esther N.
    Wen, Yong Hannah
    Akram, Muzaffar
    Ho, Alice Y.
    Gupta, Gaorav P.
    Brogi, Edi
    Hudis, Clifford A.
    Traina, Tiffany A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Androgen receptor expression in triple negative breast cancer
    Gilmore, Hannah
    Varadan, Vinay
    Williams, Nicole
    Thompson, Cheryl L.
    Kim, Stephanie
    Hsu, Peter
    Miskimen, Kristy
    Palkar, Aditi
    Vinayak, Shaveta
    Lindner, Robert
    Harris, Lyndsay
    CANCER RESEARCH, 2015, 75
  • [35] Androgen receptor expression in triple negative breast cancer
    Chelakkot, P.
    Vijayan, S.
    Ravind, R.
    Sol, V. S.
    Keechilat, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S196 - S196
  • [36] Relation of Androgen Receptor Status to Metabolic Activity in Triple-Negative Breast Cancer
    Lee, Reeree
    Lee, Han-Byoel
    Paeng, Jin Chul
    Cheon, Gi Jeong
    Lee, Dong Soo
    Chung, June-Key
    Kang, Keon Wook
    Suh, Hoon Young
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [37] Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
    Dubrava, Alex L.
    Kyaw, Pan Su Pyae
    Newman, Joseph
    Pringle, Jarrad
    Westhuyzen, Justin
    Fuentes, Gina La Hera
    Shakespeare, Thomas P.
    Sakalkale, Renukadas
    Aherne, Noel J.
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 359 - 371
  • [38] Translational relevance of androgen receptor immunohistochemistry scoring systems for data harmonization in triple negative breast cancer (TNBC).
    Mufti, Suhail Sayeed
    Lalkota, Bhanu Prakash
    Tejaswini, B. N.
    Varayathu, Hrishi
    Sarathy, Vinu
    Puii, Lalnun
    Sangi, Lalram
    Thomas, Beulah Elsa
    Hazarika, Diganta
    Thungappa, Satheesh Chiradoni
    Sriniivas, B. J.
    Patil, Shekar
    Naik, Radheshyam
    Ajaikumar, Basavalinga Sadasivaiah
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Characteristics, outcomes and prognostic factors of luminal androgen receptor (LAR) triple-negative breast cancer (TNBC)
    Leon-Ferre, R. A.
    Polley, M-Y
    Liu, H.
    Kalari, K. R.
    Boughey, J. C.
    Liu, M. C.
    Cafourek, V.
    Negron, V.
    Ingle, J. N.
    Thompson, K. J.
    Tang, X.
    Barman, P.
    Carlson, E.
    Visscher, D. W.
    Carter, J. C.
    Couch, F. J.
    Goetz, M. P.
    CANCER RESEARCH, 2019, 79 (04)
  • [40] Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients
    Medic-Milijic, Natasa
    Jovanic, Irena
    Nedeljkovic, Milica
    Markovic, Ivan
    Spurnic, Igor
    Milovanovic, Zorka
    Ademovic, Nejla
    Tomic, Tijana
    Tanic, Nasta
    Tanic, Nikola
    LIFE-BASEL, 2024, 14 (06):
12345